These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1458918)

  • 41. Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus.
    Tsokos GC; Smith PL; Balow JE
    Am J Med; 1986 Dec; 81(6):1081-4. PubMed ID: 3541592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis.
    Gibbons RB; Westerman E
    Arthritis Rheum; 1988 Dec; 31(12):1552-4. PubMed ID: 3196367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect and limitation of intravenous methylprednisolone pulse therapy in the long-term follow-up of childhood systemic lupus erythematosus].
    Yokota S; Shimizu H; Aihara Y; Mitsuda T; Ibe M; Kuriyama T; Mori T; Kosuge K
    Ryumachi; 1992 Jun; 32(3):215-22. PubMed ID: 1523523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful child bearing during intravenous cyclophosphamide therapy in a patient with systemic lupus erythematosus.
    Matsukawa Y; Nishinarita S; Horie T; Hayama T
    Br J Rheumatol; 1998 Mar; 37(3):342-3. PubMed ID: 9566680
    [No Abstract]   [Full Text] [Related]  

  • 45. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG).
    Clark WF; Dau PC; Euler HH; Guillevin L; Hasford J; Heer AH; Jones JV; Kashgarian M; Knatterud G; Lockwood CM
    J Clin Apher; 1991; 6(1):40-7. PubMed ID: 2045382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
    Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A
    J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overview of treatment of lupus nephropathy.
    Coggins CH
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclophosphamide in treatment of systemic lupus erythematosus: 7 years' experience.
    Feng PH; Jayaratnam FJ; Tock EP; Seah CS
    Br Med J; 1973 May; 2(5864):450-2. PubMed ID: 4712483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.
    Plotz PH; Klippel JH; Decker JL; Grauman D; Wolff B; Brown BC; Rutt G
    Ann Intern Med; 1979 Aug; 91(2):221-3. PubMed ID: 464465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
    Martinelli R; Pereira LJ; Santos ES; Rocha H
    Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of systemic lupus erythematosus (SLE) with a neurogenic bladder, successful treatment with intravenous cyclophosphamide pulse therapy].
    Nakagawa M; Nishinarita M
    Ryumachi; 1999 Oct; 39(5):763-7. PubMed ID: 10614171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
    Opastirakul S; Chartapisak W
    Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.
    Walport MJ; Hubbard WN; Hughes GR
    Br Med J (Clin Res Ed); 1982 Sep; 285(6344):769-70. PubMed ID: 6810992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of therapies on childhood systemic lupus erythematosus].
    Kurosawa R; Umezawa R; Kobayashi Y; Nakajima S; Miyamae T; Ito S; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
    Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of systemic lupus erythematosis with high doses of cyclophosphamide].
    Baranowska-Daca E
    Wiad Lek; 1993 Nov; 46(21-22):868-71. PubMed ID: 7817583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cyclophosphamide pulse therapy of systemic lupus erythematosus with renal involvement].
    Hein R; Neumann KH; Koch KM; Deicher H; Schmidt RE
    Immun Infekt; 1991 Apr; 19(2):57-8. PubMed ID: 1855811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis.
    Schmaldienst S; Jansen M; Hollenstein U; Graninger W; Regele H; Hörl WH; Derfler K
    Am J Kidney Dis; 2002 Feb; 39(2):415-8. PubMed ID: 11840385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frentizole therapy of active systemic lupus erythematosus.
    Kay DR; Valentine TV; Walker SE; Valentine MH; Bole GG
    Arthritis Rheum; 1980 Dec; 23(12):1381-7. PubMed ID: 7006613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.